Organovo Stock Price

0.10 (1.42%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Organovo Holdings Inc ONVO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.10 1.42% 7.13 18:00:00
Open Price Low Price High Price Close Price Prev Close
7.12 6.93 7.24 7.13 7.03
Bid Price Ask Price Spread News
7.01 7.28 0.27 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
581 29,471 $ 7.13 $ 210,259 - 6.05 - 23.92
Last Trade Time Type Quantity Stock Price Currency
16:00:16 priorref 304 $ 7.13 USD


Draw Mode:

Organovo Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 62.07M 8.71M 8.64M $ - $ - -2.43 -3.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 10.75k -

more financials information »

Organovo News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ONVO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.187.4056.867.0955,016-0.05-0.7%
1 Month7.60148.206.867.4745,947-0.4714-6.2%
3 Months8.758.766.057.5461,099-1.62-18.51%
6 Months9.2811.256.058.63169,705-2.15-23.17%
1 Year6.6023.926.0511.33234,6160.538.03%
3 Years1.1723.920.19331.82722,9215.96509.4%
5 Years3.8923.920.19332.01862,5033.2483.29%

Organovo Description

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.